Wikisage, the free encyclopedia of the second generation, is digital heritage
Aspirin: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
A recommendation of AAs-clopidogrel to maintain the patency of the stent following coronary intervention. Clopidogrel is a P2Y12 inhibig platelet agent; the combination AAs Ticagrelor wasn´t better than clopidogrel+aspirin | A recommendation of AAs-clopidogrel to maintain the patency of the stent following coronary intervention. Clopidogrel is a P2Y12 inhibig platelet agent; the combination AAs Ticagrelor wasn´t better than clopidogrel+aspirin | ||
<ref>https://www.mdpi.com/2077-0383/8/1/104/htm Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting]</ref> | <ref>https://www.mdpi.com/2077-0383/8/1/104/htm Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting]</ref> | ||
==Kawasaki== | |||
<ref>[http://www.e-mjm.org/2018/v73n6/refractory-kawasaki-disease.pdf A case report of refractory kawasaki disease]</ref> | <ref>[http://www.e-mjm.org/2018/v73n6/refractory-kawasaki-disease.pdf A case report of refractory kawasaki disease]</ref> | ||
==Links== | ==Links== | ||
[https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-019-3872-0 Level and variation on quality of care in China: a cross-sectional study for the acute myocardial infarction patients in tertiary hospitals in Beijing] | [https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-019-3872-0 Level and variation on quality of care in China: a cross-sectional study for the acute myocardial infarction patients in tertiary hospitals in Beijing] | ||
<references/> | <references/> | ||
{{Wikidata|Q}} | {{Wikidata|Q}} | ||
Revision as of 11:59, 24 January 2019
Aspirin is an AINE [1] A recommendation of AAs-clopidogrel to maintain the patency of the stent following coronary intervention. Clopidogrel is a P2Y12 inhibig platelet agent; the combination AAs Ticagrelor wasn´t better than clopidogrel+aspirin [2]
Kawasaki
Links
- ↑ https://karmel.miraheze.org/wiki/PenaRC2/profilaxis_AAS
- ↑ https://www.mdpi.com/2077-0383/8/1/104/htm Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting]
- ↑ A case report of refractory kawasaki disease
